Tirzepatide

Tirzepatide

Dual GIP / GLP-1 receptor analog.

$60CAD · Excl. tax≈ $6.00 / mgOut of stock
Size · 2 optionsSKU PB-TIRZ-10
  • HPLC
    ≥99.5%
  • COA
    Signed
  • Shipping
    Vancouver
  • Origin
    🇨🇦 Vancouver

Optional Temperature Protection $9.99 CAD · 14-day analytical guarantee

Purity
99.5%
Presentation
30mg · 10mg, lyophilised
Molecular formula
C₂₂₅H₃₄₈N₄₈O₆₈
Molecular mass
4813.53 g/mol
Storage
−20°C, protected from light
Verification
HPLC · MS · Endotoxin
Batch verification
Verify by QR

What is Tirzepatide?

Tirzepatide is a synthetic peptide investigated as a dual GIP and GLP-1 receptor agonist. It is a subject of metabolic research literature exploring incretin signaling and energy-regulation pathways.

Peptibolics supplies Tirzepatide strictly as a research material for laboratory investigation.

01

Research Overview

The following summarizes areas that published scientific literature has explored. These statements describe research findings in experimental models and are provided for educational purposes only.

02

Dual incretin receptor research

Research has investigated tirzepatide's combined activity at the GIP and GLP-1 receptors, pathways of interest in glucose- and energy-homeostasis science.

03

Metabolic research models

Preclinical and clinical literature has examined dual incretin agonists in models of metabolic regulation.

04

Available vial sizes

30mg, 10mg

05

Purity

≥99% (HPLC verified)

06

Quality & Testing

Every lot of Peptibolics Tirzepatide is verified by third-party laboratory analysis for identity and purity, with a certificate of analysis (COA) available for the corresponding lot.

Mechanism of action

How Tirzepatide interacts with cellular systems.

  • 01Dual agonist at GIP and GLP-1 receptors.
  • 02C20 fatty-acid diacid moiety mediates albumin binding for extended half-life.
  • 03Modulates insulin, glucagon and gastric emptying signalling in preclinical models.
  • 04Synergistic incretin activity distinct from mono-agonist compounds.
Research applications

Where this compound appears in the literature.

  • Dual incretin receptor pharmacology
  • Comparative metabolic assays vs. mono-agonists
  • Long-acting analog PK/PD studies
  • Adipose and hepatocyte metabolic research
Specifications

Analytical release specification.

Every batch is released against this specification. Batch-specific values are printed on the accompanying Certificate of Analysis.

Compound
Tirzepatide
CAS number
2023788-19-2
Sequence
Modified 39-mer with C20 diacid at Lys²⁰
Molecular formula
C₂₂₅H₃₄₈N₄₈O₆₈
Molecular mass
4813.53 g/mol
Purity (HPLC)
≥99.5%
Mass confirmation
ESI-MS · matches theoretical
Endotoxin
< 0.5 EU/mg
Appearance
White lyophilised powder
Solubility
Water, PBS
Presentation
30mg · 10mg, lyophilised · acetate salt
Storage
−20°C, protected from light
Shelf life
24 months from date of manufacture
Research use
For in vitro laboratory research only
Handling & reconstitution

Bench-ready protocol.

Reconstitution

Reconstitute with bacteriostatic water; slow addition along vial wall.

Handling

Aseptic aliquoting. Low-bind tubes.

Storage

Lyophilised: −20°C. Reconstituted: 2–8°C up to 28 days.

HPLC
≥99.5% purity
ESI-MS
Identity confirmed
LAL
< 0.5 EU/mg
Shipping
Vancouver → Canada-wide
Verified researcher reviews

From the labs using Tirzepatide.

5.0
3 verified reviews

Reviews are submitted by verified researchers and institutions after batch delivery. Identity abbreviated for privacy.

  • Verified

    Dual-receptor activity confirmed.

    Binding assays match published affinity for both GIP and GLP-1 receptors. Excellent documentation.

    O.N.Metabolic pharmacology researcher
  • Verified

    Best-in-class Canadian supplier.

    We source multiple incretin analogs from Peptibolics. Consistency is superior to previous vendors.

    I.F.Senior scientist — diabetes research
  • Verified

    Delivered next-day to Calgary.

    Packaging arrived intact and premium. HPLC matches COA exactly.

    Q.L.Postdoc — adipose biology
Frequently asked

Questions researchers ask us about Tirzepatide.

Can't find your answer? Contact our lab team.

7 answered

Tirzepatide is supplied in Canada as a research chemical for laboratory use only. It is not approved by Health Canada for human or veterinary use and is not sold for consumption.

It is investigated as a dual GIP/GLP-1 receptor agonist within metabolic research literature.

Each lot is verified for identity and purity by third-party HPLC analysis, with a COA available.

Every batch of Tirzepatide is HPLC-verified to ≥99% purity, mass-confirmed by ESI-MS, and endotoxin-tested to <0.5 EU/mg. A batch-specific Certificate of Analysis is available on this page and inside every shipment.

Orders placed before 14:00 PT ship same-day from Vancouver via tracked courier. Standard transit is 1–3 business days nationwide. Optional Temperature Protection ($9.99 CAD) adds insulated packaging with phase-change coolant to maintain 2–8°C for heat-sensitive orders.

Yes. A signed COA is downloadable directly from this product page and includes HPLC chromatogram, mass spectrum, sequence confirmation, appearance, water content and endotoxin result — traceable to the batch number printed on your vial.

Peptibolics compounds are supplied strictly for in vitro laboratory research. By ordering you confirm you are a qualified researcher or institution and will not administer product to humans or animals. All sales are final.

Research use only. Tirzepatide is supplied strictly for in vitro laboratory research. Not for human or veterinary use. By purchasing you confirm you are a qualified researcher acting within applicable law.

Read our quality standard →
Related

Compounds in Metabolic

View catalog →
Tirzepatide
$60 · 30mg · 10mg